|
CCT6A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.78699952005468E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.383200E-04 |
| Normal-vs-Stage2 |
3.372000E-02 |
| Normal-vs-Stage3 |
1.216460E-03 |
| Normal-vs-Stage4 |
8.724700E-03 |
| Stage1-vs-Stage2 |
7.324600E-01 |
| Stage1-vs-Stage3 |
2.204300E-02 |
| Stage1-vs-Stage4 |
1.003960E-02 |
| Stage2-vs-Stage3 |
2.041000E-01 |
| Stage2-vs-Stage4 |
5.393800E-02 |
| Stage3-vs-Stage4 |
4.600200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12590000048252E-08 |
| Normal-vs-AfricanAmerican |
1.840530E-04 |
| Normal-vs-Asian |
1.377830E-01 |
| Caucasian-vs-AfricanAmerican |
7.346800E-01 |
| Caucasian-vs-Asian |
2.017800E-01 |
| AfricanAmerican-vs-Asian |
3.688000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50040000213414E-08 |
| Normal-vs-Female |
1.70239999996991E-06 |
| Male-vs-Female |
1.391830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.902200E-03 |
| Normal-vs-Extreme_Weight |
3.406900E-04 |
| Normal-vs-Obese |
2.619100E-04 |
| Normal-vs-Extreme_Obese |
4.474200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.214400E-01 |
| Normal_Weight-vs-Obese |
8.868400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.399600E-01 |
| Extreme_Weight-vs-Obese |
1.775410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.966000E-01 |
| Obese-vs-Extreme_Obese |
2.814000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.942930E-03 |
| Normal-vs-Age(41-60Yrs) |
6.09660000261414E-09 |
| Normal-vs-Age(61-80Yrs) |
2.031500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.931400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.721400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.349600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.105010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.582030E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.331600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.117600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.5841999984344E-08 |
| Normal-VS-Type2 PRCC |
6.177700E-04 |
| Normal-VS-KIRP CIMP |
9.881200E-03 |
| Normal-VS-Unclassified PRCC |
7.798500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.052000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.232000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.919400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.663000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.191800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.222000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.418400E-02 |
| Normal-vs-N1 |
3.80050000000631E-05 |
| Normal-vs-N2 |
5.542200E-01 |
| N0-vs-N1 |
9.979100E-04 |
| N0-vs-N2 |
9.406800E-01 |
| N1-vs-N2 |
1.439200E-01 |
|
|
